APO RESEARCH · REPORT
Zika Virus Testing
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Product & engineering
Understand the product.
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Selected research
Industry Growth & Trends
Global Zika Virus Testing Industry Growth and Trends Forecast to 2032
Market perspective
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
According to APO Research, the global Zika Virus Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Zika Virus Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Zika Virus Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Zika Virus Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Zika Virus Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Zika Virus Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Zika Virus Testing Market by Company
Chembio
Quest Diagnostics
ARUP Laboratories
Luminex
Simens
Abbott Molecular
Hologic
ELITech Molecular Diagnostics
EUROIMMUN US
Creative Diagnostics
Vela Diagnostics
InBios International
Primerdesign
Altona Diagnostics
Zika Virus Testing Segment by Type
Molecular Test
Serologic Test
Zika Virus Testing Segment by Application
Diagnostic Centers
Hospitals
Pathology Labs
Zika Virus Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Zika Virus Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Zika Virus Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Molecular Test
- Serologic Test
Applications
- Diagnostic Centers
- Hospitals
- Pathology Labs
Companies covered
- Chembio
- Quest Diagnostics
- ARUP Laboratories
- Luminex
- Simens
- Abbott Molecular
- Hologic
- ELITech Molecular Diagnostics
- EUROIMMUN US
- Creative Diagnostics
- Vela Diagnostics
- InBios International
- Primerdesign
- Altona Diagnostics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Zika Virus Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Zika Virus Testing Market Size by Region (2021-2032)
- 1.4.1 Global Zika Virus Testing Market Size by Region (2021-2026)
- 1.4.2 Global Zika Virus Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Zika Virus Testing Market Size (2021-2032)
- 1.5.1 North America Zika Virus Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Zika Virus Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Zika Virus Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Zika Virus Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Zika Virus Testing Market Size Growth Rate (2021-2032)
2 Zika Virus Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 Molecular Test
- 2.1.2 Serologic Test
- 2.2 Global Zika Virus Testing Market Size by Type
- 2.2.1 Global Zika Virus Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Zika Virus Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Zika Virus Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Zika Virus Testing Market Size by Regions
- 2.3.1 North America Zika Virus Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Zika Virus Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Zika Virus Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Zika Virus Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Zika Virus Testing Market Size Breakdown by Type (2021-2026)
3 Zika Virus Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Diagnostic Centers
- 3.1.2 Hospitals
- 3.1.3 Pathology Labs
- 3.2 Global Zika Virus Testing Market Size by Application
- 3.2.1 Global Zika Virus Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Zika Virus Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Zika Virus Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Zika Virus Testing Market Size by Regions
- 3.3.1 North America Zika Virus Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Zika Virus Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Zika Virus Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Zika Virus Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Zika Virus Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Zika Virus Testing Industry Trends
- 4.2 Zika Virus Testing Industry Drivers
- 4.3 Zika Virus Testing Industry Opportunities and Challenges
- 4.4 Zika Virus Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Zika Virus Testing Revenue (2021-2026)
- 5.2 Global Zika Virus Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Zika Virus Testing Key Company Headquarters & Area Served
- 5.4 Global Zika Virus Testing Company, Product Type & Application
- 5.5 Global Zika Virus Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Zika Virus Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Zika Virus Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Zika Virus Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Chembio
- 6.1.1 Chembio Company Information
- 6.1.2 Chembio Business Overview
- 6.1.3 Chembio Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Chembio Zika Virus Testing Product Portfolio
- 6.1.5 Chembio Recent Developments
- 6.2 Quest Diagnostics
- 6.2.1 Quest Diagnostics Company Information
- 6.2.2 Quest Diagnostics Business Overview
- 6.2.3 Quest Diagnostics Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Quest Diagnostics Zika Virus Testing Product Portfolio
- 6.2.5 Quest Diagnostics Recent Developments
- 6.3 ARUP Laboratories
- 6.3.1 ARUP Laboratories Company Information
- 6.3.2 ARUP Laboratories Business Overview
- 6.3.3 ARUP Laboratories Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 ARUP Laboratories Zika Virus Testing Product Portfolio
- 6.3.5 ARUP Laboratories Recent Developments
- 6.4 Luminex
- 6.4.1 Luminex Company Information
- 6.4.2 Luminex Business Overview
- 6.4.3 Luminex Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Luminex Zika Virus Testing Product Portfolio
- 6.4.5 Luminex Recent Developments
- 6.5 Simens
- 6.5.1 Simens Company Information
- 6.5.2 Simens Business Overview
- 6.5.3 Simens Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Simens Zika Virus Testing Product Portfolio
- 6.5.5 Simens Recent Developments
- 6.6 Abbott Molecular
- 6.6.1 Abbott Molecular Company Information
- 6.6.2 Abbott Molecular Business Overview
- 6.6.3 Abbott Molecular Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Abbott Molecular Zika Virus Testing Product Portfolio
- 6.6.5 Abbott Molecular Recent Developments
- 6.7 Hologic
- 6.7.1 Hologic Company Information
- 6.7.2 Hologic Business Overview
- 6.7.3 Hologic Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Hologic Zika Virus Testing Product Portfolio
- 6.7.5 Hologic Recent Developments
- 6.8 ELITech Molecular Diagnostics
- 6.8.1 ELITech Molecular Diagnostics Company Information
- 6.8.2 ELITech Molecular Diagnostics Business Overview
- 6.8.3 ELITech Molecular Diagnostics Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 ELITech Molecular Diagnostics Zika Virus Testing Product Portfolio
- 6.8.5 ELITech Molecular Diagnostics Recent Developments
- 6.9 EUROIMMUN US
- 6.9.1 EUROIMMUN US Company Information
- 6.9.2 EUROIMMUN US Business Overview
- 6.9.3 EUROIMMUN US Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 EUROIMMUN US Zika Virus Testing Product Portfolio
- 6.9.5 EUROIMMUN US Recent Developments
- 6.10 Creative Diagnostics
- 6.10.1 Creative Diagnostics Company Information
- 6.10.2 Creative Diagnostics Business Overview
- 6.10.3 Creative Diagnostics Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Creative Diagnostics Zika Virus Testing Product Portfolio
- 6.10.5 Creative Diagnostics Recent Developments
- 6.11 Vela Diagnostics
- 6.11.1 Vela Diagnostics Company Information
- 6.11.2 Vela Diagnostics Business Overview
- 6.11.3 Vela Diagnostics Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Vela Diagnostics Zika Virus Testing Product Portfolio
- 6.11.5 Vela Diagnostics Recent Developments
- 6.12 InBios International
- 6.12.1 InBios International Company Information
- 6.12.2 InBios International Business Overview
- 6.12.3 InBios International Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 InBios International Zika Virus Testing Product Portfolio
- 6.12.5 InBios International Recent Developments
- 6.13 Primerdesign
- 6.13.1 Primerdesign Company Information
- 6.13.2 Primerdesign Business Overview
- 6.13.3 Primerdesign Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Primerdesign Zika Virus Testing Product Portfolio
- 6.13.5 Primerdesign Recent Developments
- 6.14 Altona Diagnostics
- 6.14.1 Altona Diagnostics Company Information
- 6.14.2 Altona Diagnostics Business Overview
- 6.14.3 Altona Diagnostics Zika Virus Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Altona Diagnostics Zika Virus Testing Product Portfolio
- 6.14.5 Altona Diagnostics Recent Developments
7 North America
- 7.1 North America Zika Virus Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Zika Virus Testing Market Size by Country (2021-2026)
- 7.3 North America Zika Virus Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Zika Virus Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Zika Virus Testing Market Size by Country (2021-2026)
- 8.3 Europe Zika Virus Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Zika Virus Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Zika Virus Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Zika Virus Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Zika Virus Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Zika Virus Testing Market Size by Country (2021-2026)
- 10.3 South America Zika Virus Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Zika Virus Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Zika Virus Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Zika Virus Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst